Abuse-deterrent formulation technologies: Opportunities and limitations

Alyn McNaughton authored this article for Tablets & Capsules' January issue.

Too many Americans are misusing or abusing prescription opioids. This article summarizes recent FDA initiatives in this area and assesses the technologies manufacturers have adopted to curb abuse.

Download

To View, Please Provide the Following

To access all of the latest news, white papers, webinars and knowledge center resources, Create An Account. Already have a Capsugel account? Log In

To view this item, Sign Up for a free account

Get access to the latest news, additional whitepapers, webinars and Knowledge Center content. Already have an account? Log In

Thanks for creating an account with Capsugel!

You now have access to the latest news, whitepapers, webinars and Knowledge Center content.

Thanks for contacting Capsugel

A representative will be in touch.

Continue Browsing Privacy Policy